RxDoctor Payments Data

Edward Mackay, MD

Vascular Surgery · Palm Harbor, FLNPI 1770548505

Payments from drug & device makers

What this record shows

This record is dominated by royalties or licence payments: $14,996 of the $17,211 with a category attached, or 87.1%. Medtronic accounts for 88.8% of it on its own, with 13 other manufacturers making up the rest. Reporting peaked in 2019 at $15,338 and has fallen 98.7% since, to $200 in 2025.

$17,211in general payments, 2019–2025

Across 77 payments — averaging $223.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$15K
  • Bard Peripheral Vascular, Inc.$615
  • Boston Scientific$438
  • Organogenesis Inc.$291
  • Venclose Inc.$140
  • Celonova Biosciences, Inc.$100
  • plus $345 from 8 others
$149,706in ownership & investment interests, 2019–2025

Across 3 payments — averaging $49,902 each. An ownership or investment interest held by the physician or an immediate family member.

  • Corvista Health, Inc.$150K
  • Cardio Flow, Inc.$0

What the payments were for

  • Royalty or licence$14,99687%
  • Food & beverage$2,21513%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Medtronic(2 entities)10$15,282
Bard Peripheral Vascular, Inc.15$615
Boston Scientific15$438
Organogenesis Inc.14$291
Venclose Inc.5$140
Celonova Biosciences, Inc.1$100
AbbVie(2 entities)4$83
Merz North America, Inc.2$73
Biocompatibles, Inc.3$56
Cook Medical LLC2$38
Cashflow Solutions, LLC3$32
EKOS Corporation1$24
Convatec Inc.1$22
Bioventus LLC1$16

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$17,211 in reported general payments places this provider in the 75th percentile of 385 vascular surgery providers in Florida.

See all vascular surgery providers in Florida

Medicare billing

Part B allowed, 2024
$455,013
Medicare patients
440
Services billed
1,583

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other vascular surgery in Palm Harbor

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →